Macquarie Group’s Aceragen Inc ACGN Stock Holding History

Macquarie Group’s Portfolio ACGN Stock Details ACGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-115	Closed	-$33K	–	2430
2017 Q4	$33K	Buy	+115	New	+$32.8K	﹤0.01%	2085
2016 Q1	–	Sell	-966	Closed	-$406K	–	1604
2015 Q4	$406K	Buy	+966	New	+$432K	﹤0.01%	1214

Other funds holding ACGN

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Natixis Paris, France $28B AUM 26.79% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return

Macquarie Group's ACGN Position: Q1 2018 in Review

Macquarie Group sold out of Aceragen Inc (ACGN) in Q1 2018, closing a stake of 115 shares — an estimated $33K sold.

Macquarie Group first reported a position in ACGN in Q4 2015 and held it in 2 quarters. The position peaked at $406K in Q4 2015. 107 funds tracked by Wall St. Rank hold ACGN as of Q1 2018.

Macquarie Group reported no remaining Aceragen Inc position as of Q1 2018 after selling out during the quarter.
Macquarie Group sold 115 Aceragen Inc shares in Q1 2018, an estimated $33K.
Macquarie Group first reported a position in Aceragen Inc in Q4 2015 and held it in 2 quarters.
Macquarie Group's Aceragen Inc position peaked at $406K in Q4 2015.
107 funds tracked by Wall St. Rank held Aceragen Inc as of Q1 2018.

Based on Macquarie Group's 13F filing for Q1 2018, filed 11 May 2018.